Fungal enzymes could replace pig enzymes for digestive aid in pancreatitis

NCT ID NCT07697352

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial compares fungal-based pancreatic enzymes to standard pig-derived enzymes in people with chronic pancreatitis and digestive insufficiency. Participants take either the fungal or porcine enzyme for 12 weeks to see if the fungal version works just as well. The goal is to provide a non-porcine option that respects religious and dietary preferences.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fungal-based pancreatic enzymes (amylase, lipase, protease)
What this could lead to
If successful, this could offer a culturally acceptable, non-porcine alternative for managing pancreatic enzyme insufficiency, avoiding religious or dietary conflicts.
What could go wrong
This is a single-center trial with 134 participants, so results may not apply broadly. The fungal enzymes might not match the effectiveness of the standard porcine treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXOCRINE PANCREATIC INSUFFICIENCY (EPI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.